Completed
Study of the Safety of FG-3019 in Incipient Nephropathy Due to Type 1 or Type 2 Diabetes Mellitus
NCT00102297
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- UCLA - LA BioMed Los Angeles, California, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Radiant Research Dallas, Texas, United States
- Diabetes & Glandular Disease San Antonio, Texas, United States